Adequate dosing for second-generation antipsychotics in establishing treatment resistance in schizophrenia

American Journal of Psychiatry

Volumn 171, Issue 1, 2014, Pages 118-119

  Lee, Jimmy ^a,b,c   Remington, Gary ^a,b,c  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

CLINICAL EFFECTIVENESS; DOSE CALCULATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; LETTER; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; TREATMENT DURATION;

ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; SCHIZOPHRENIA; TREATMENT FAILURE;

EID: 84891684167     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.13070965     Document Type: Letter

References (8)

1. Conley RR, Kelly DL: Management of treatment resistance in schizophrenia. Biol Psychiatry 2001;50:898-911 (Pubitemid 34020701)
2. Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatmentresistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
3. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W; Schizophrenia Patient Outcomes Research Team (PORT): The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36:71-93
4. Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders: The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry 2003;64(suppl 12):5-19
5. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ: International consensus study of antipsychotic dosing. Am J Psychiatry 2010;167:686-693
6. Woods SW: Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667 (Pubitemid 36750143)
7. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC: Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010;67:255-262
8. Davis JM, Chen N: Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol 2004;24:192-208 (Pubitemid 38380844)